Bioquell Regulatory News (BQE)

27 June, 2011

BIOQUELL PLC

Completion of the registration of Bioquell China

Award of c. US$ 1 million contract for specialist bio-decontamination equipment to be used by the Chinese Ministry of Agriculture

Bioquell PLC (LSE: BQE) ("Bioquell") - provider of specialist low temperature, residue-free bio-decontamination technologies to the healthcare, life sciences and defence sectors - announces that the Chinese authorities have completed the approvals necessary for the registration of Bioquell China.

In addition, Bioquell announces that it has been awarded a contract to supply specialist hydrogen peroxide vapour bio-decontamination equipment to research organisations within the Chinese Government's Ministry of Agriculture worth approximately US$1 million. This bio-decontamination equipment is scheduled to be shipped in the second half of the year - and will be installed and serviced by Bioquell China.

Commenting on this contract award in China, Nick Adams, Group Chief Executive of Bioquell PLC, said:

"We are delighted to have won a significant first contract for our unique hydrogen peroxide vapour bio-decontamination equipment from Chinese government research organisations."

"This contract award helps demonstrate the benefits of our substantial investment in the Asia Pacific region - and specifically the establishment of Bioquell China."

- Ends -

Enquiries:

Bioquell PLC 01264 835 900

Nick Adams Group Chief Executive

Mark Bodeker Chief Operating Officer / Finance Director

Notes to editors:

§ Bioquell is a UK-headquartered, international technology company with two divisions:

o Bio-decontamination which sells specialist bio-decontamination products and services into the Healthcare, Life Sciences and Defence sectors, with most of its revenues generated from overseas customers; and

o TRaC which provides UK corporates with specialist Testing, Regulatory and Compliance services - many of which are required by national and international regulations.

§ Bioquell's gas phase bio-decontamination technology uses hydrogen peroxide vapour - which is highly efficacious at eradicating micro-organisms such as bacteria, viruses and fungi at room temperature - and is subsequently broken down using specialist catalysts to water vapour and oxygen at the end of the bio-decontamination process.

§ Bioquell's bio-decontamination technology:

o is used by bio-pharmaceutical, biologics, biotechnology and research institutions to provide sterile equipment and/or sterile working environments - which is of particular interest to organisations working with biologically-derived drugs;

o is also used by researchers involved in the study of zoonotic transfer whereby diseases in animals can be transferred to humans - with examples including SARS (which is believed to have originated in China) and porcine swine fever (which originated in Mexico)

o is used to eradicate drug resistant organisms associated with Hospital Acquired Infection as well as problematic viruses from the hospital environment. Independent scientific research has demonstrated that 'bioquelling' hospital equipment and facilities reduces the rates of hospital acquired infection;

o was selected by the United States Department of Defense for the JSSED programme to decontaminate sensitive equipment against biological and chemical warfare agents;

o benefits from a number of granted or pending patent filings in the UK and internationally;

o is used in other sectors where bioburden can create significant problems including, for example, the food industry; and

o also comprises specialist filtration technology including peroxide catalysis and chemical, biological, radiological and nuclear ("CBRN") filtration systems used principally in the defence sector.

§ Bioquell currently has overseas operations in the USA, France, Ireland, Singapore and China.

§ TRaC sells its specialist testing services to the product development and engineering departments of a broad range of companies and organisations, principally based in the UK, with a particular focus on the aerospace, military and telecoms sectors.